No amount of
hepatitis B vaccine or
hepatitis B and hepatitis C drugs can control the spread of viral hepatitis if there is no monitoring of at-risk communities, no information about disease prevention and management, or no training for primary healthcare professionals to diagnose and refer cases to clinicians to treat the diseases.
In 2016, 1.1 million people newly developed chronic
hepatitis B infection - a primary cause of liver cancer.
He said untreated, patients of
Hepatitis B and C can develop liver cirrhosis and hepatocellular carcinoma (HCC), commonly known as liver cancer.
'There is no question that the Americas have had substantial success in infant vaccination against
hepatitis B which will save millions of lives.
Of course, the consequences that follow getting a
hepatitis B, like chronic hepatitis, liver cirrhosis and liver cancer, could be deadly.
Ninety six percent of these deaths are attributable to infection with the
hepatitis B virus and/or the hepatitis C virus.
In the initial stages, chronic infections, of
Hepatitis B and C, the symptoms may not appear14.
Globally, approximately 257 million persons are chronically infected with
Hepatitis B and 71 million with Hepatitis C.
Conclusion: The frequency of
hepatitis B and C was 1% and 2% respectively in Rawalakot, Pakistan, with male preponderance in
hepatitis B.
Hepatitis B gravely affects the Asia Pacific, killing a person every 30 seconds, according to the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP).
The strategy includes a target to treat 8 million persons for
hepatitis B or C by 2020.
According to the data of Khyber Pakhtunkhwa Health Department around 50,000 patients of hepatitis were in KP as 37,000 were hepatitis C patients while more than 10,000 were
hepatitis B patients.